SPDR DOW 30 ETF (DIA) 181.87 $DIA More Signs Point To A

New Post Public Reply Private Reply Replies (0) Message Board

Mar 3, 2015 at 7:59 PM

SPDR DOW 30 ETF (DIA) 181.87 $DIA

More Signs Point To A Slowdown In Q1 U.S. Growth
Hale Stewart - Seeking Alpha - Tue Mar 03, 1:51PM CST
Beginning in autumn 2013 and continuing through spring 2014, the housing market stalled in response to higher interest rates. Because of that, I anticipated an economic slowdown at about the end of 2014. More signs are emerging that the slowdown has...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), IWM: 122.74 (-0.73)

ADP Employment Report: February 2015 Preview
James Picerno - Seeking Alpha - Tue Mar 03, 1:40PM CST
Private nonfarm payrolls in the US are projected to increase by 213,000 (seasonally adjusted) in tomorrow’s February update of the ADP Employment Report, based on The Capital Spectator’s median point forecast for several econometric...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), IWM: 122.74 (-0.73)

Protect Your Stock Portfolio Now While Volatility Is Low
at The Street - Tue Mar 03, 1:28PM CST
The CNBC ‘Fast Money Halftime’ trading panel looked at the market's current low volatility and how investors can use it to protect their long positions.
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), OIH: 34.91 (+0.12), XOP: 50.59 (+0.65), C: 53.73 (+0.24), DIA: 181.87 (-0.81), AAL: 48.77 (+0.46), BP: 41.74 (+0.44), IWM: 122.74 (-0.73), TLT: 126.41 (-0.46), XLE: 78.76 (+0.29)

10 Charts To Watch
Calafia Beach Pundit - Seeking Alpha - Tue Mar 03, 1:17PM CST
The news and the economic fundamentals haven't changed much in recent months, but on the margin there has been some modest improvement. The following charts highlight some of the more interesting developments that bear watching. (click to enlarge) ...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81)

Optimism/Pessimism: Stocks At Record Highs, While Savings Rate Jumps
Joseph Calhoun - Seeking Alpha - Tue Mar 03, 8:07AM CST
By Jeffrey P. Snider Stocks had a great day today unshaken by whether the manufacturing part of the economy was growing more quickly or at the slowest rate in 13 months. Confusion isn't part of the asset inflation lexicon . In economic news, the...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81)

Futures edge lower
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 6:21AM CST

SPUU: 147.11 (-1.36), SPLX: 32.69 (+0.34), TQQQ: 112.66 (-1.64), SDOW: 18.68 (+0.23), DOG: 22.61 (+0.09), SPXU: 34.44 (+0.40), UPRO: 141.90 (-1.78), SPY: 211.12 (-0.87), EPS: 73.20 (-0.32), DXD: 20.48 (+0.18), QQXT: 42.13 (-0.08), SQQQ: 24.86 (+0.34), DIA: 181.87 (-0.81), SPXL: 93.94 (-1.19), QID: 35.07 (+0.34), SFLA: 180.57 (unch), RWL: 41.84 (-0.09), RSP: 82.25 (-0.31), SH: 21.12 (+0.09), SSO: 134.62 (-1.15), QQEW: 44.70 (-0.32), IVV: 212.60 (-0.96), QQQE: 66.53 (-0.45), DDM: 140.97 (-1.29), BXUC: 299.86 (unch), QLD: 151.26 (-1.50), VOO: 193.64 (-0.83), QQQ: 108.87 (-0.51), SDS: 20.69 (+0.17), BXUB: 201.74 (unch), PSQ: 56.14 (+0.28), UDOW: 150.49 (-2.01)

Happy 6th Birthday, Bull Market! Can You Hang On A Little Longer?
Louis Navellier - Seeking Alpha - Tue Mar 03, 5:08AM CST
By Gary Alexander Six years ago, if you can put yourself back into that panicky state of mind, it seemed like the world was about to end. It didn't matter if you were a growth investor or an income investor. Both got hammered. In late February,...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81)

The Conference
Jeffrey Saut - Seeking Alpha - Tue Mar 03, 5:00AM CST
Greetings from Orlando where the Raymond James 36th Annual Institutional Investors Conference is in full swing. At this year's conference there will be more than 1,000 portfolio managers (PMs) and analysts, as well as more than 300 companies...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81)

How Janet Yellen's Latest Swindle Works
Bonner & Partners - Seeking Alpha - Tue Mar 03, 3:44AM CST
by Bill Bonner Commentators spent the weekend trying to figure out what Janet Yellen's testimony before the Senate meant for markets. What did she say? What did it mean? Why was she there at all? "It is important to emphasize that a...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81)

Nasdaq Has Room to Run Over 5,000, Lumber Liquidators Crushed
at The Street - Mon Mar 02, 1:29PM CST
The CNBC 'Fast Money Halftime' traders discussed whether the Nasdaq can go yet higher.
AMZN: 384.61 (-1.04), HD: 116.07 (-0.05), FB: 79.60 (-0.15), FRC: 57.46 (unch), LL: 40.78 (+1.95), INTC: 34.10 (+0.04), TLT: 126.41 (-0.46), CME: 97.09 (-0.03), SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), LOW: 75.01 (-0.08), BP: 41.74 (+0.44), IWM: 122.74 (-0.73), MSFT: 43.28 (-0.60), AAPL: 129.36 (+0.27), CSCO: 29.54 (-0.65)

Major Asset Classes: Feb 2015 Performance Review
James Picerno - Seeking Alpha - Mon Mar 02, 12:23PM CST
February witnessed a bit of mean reversion among the major asset classes as the winners and losers at the extremes in recent history traded places last month. The bearish trend in commodities (Bloomberg Commodity Index) eased as the asset class...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81)

The Week Ahead for Global Markets - Analyst Blog
John Blank - Zacks Investment Research - Mon Mar 02, 11:39AM CST
This week, macro-data is being trumped by central bank actions around the world.
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81)

Market Hinges On 2 Key Issues
Markos Kaminis - at Seeking Alpha - Mon Mar 02, 11:37AM CST

VTI: 109.24 (-0.45), SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), IWM: 122.74 (-0.73)

Daily State Of The Markets: China, Europe, Fed Remain Focal Points For Markets
David Moenning - Seeking Alpha - Mon Mar 02, 8:18AM CST
The big news over the weekend involved China. First, in a surprise move, the People's Bank of China cut interest rates by 25 basis points. The PBOC said the move was intended to keep rates at levels suitable to the current fundamental trends in...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), IWM: 122.74 (-0.73)

John Hussman: Plan To Exit Stocks Within The Next 8 Years? Exit Now
John Hussman - Seeking Alpha - Mon Mar 02, 7:36AM CST
Excerpt from the Hussman Funds' Weekly Market Comment (3/2/15): Unless we observe a rather swift improvement in market internals and a further, material easing in credit spreads – neither which would relieve the present overvaluation...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), IWM: 122.74 (-0.73)

Market Outlook - What We're Watching Closely Here
Price Headley, CFA - Seeking Alpha - Mon Mar 02, 7:29AM CST
Believe it or not, the S&P 500 (SPX) (NYSEARCA: SPY ) lost ground last week. It was a "just barely" situation, and the Russell 2000 (RUT) (NYSEARCA: IWM ) as well as the NASDAQ Composite (COMP) (NASDAQ: QQQ ) both ended the week higher even with...
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), VXX: 27.28 (+0.58), DIA: 181.87 (-0.81), IWM: 122.74 (-0.73)

IHS Chief Economist Nariman Behravesh: GDP Up 3% Next 2 - 3 Years, Then Slows. Stocks: No Correction
Harlan Levy - at Seeking Alpha - Mon Mar 02, 7:22AM CST

SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), IWM: 122.74 (-0.73)

Technical Charts Show Stocks Are in Dangerously High Territory
at The Street - Mon Mar 02, 7:14AM CST
All five major equity averages have positive weekly chart profiles with the Nasdaq and Russell 2000 now showing overbought conditions.
SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81)

Futures flat, ISM manufacturing on tap
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 6:14AM CST

SPUU: 147.11 (-1.36), SPLX: 32.69 (+0.34), TQQQ: 112.66 (-1.64), SDOW: 18.68 (+0.23), DOG: 22.61 (+0.09), SPXU: 34.44 (+0.40), UPRO: 141.90 (-1.78), SPY: 211.12 (-0.87), EPS: 73.20 (-0.32), DXD: 20.48 (+0.18), QQXT: 42.13 (-0.08), SQQQ: 24.86 (+0.34), DIA: 181.87 (-0.81), SPXL: 93.94 (-1.19), QID: 35.07 (+0.34), SFLA: 180.57 (unch), RWL: 41.84 (-0.09), RSP: 82.25 (-0.31), SH: 21.12 (+0.09), SSO: 134.62 (-1.15), QQEW: 44.70 (-0.32), IVV: 212.60 (-0.96), QQQE: 66.53 (-0.45), DDM: 140.97 (-1.29), BXUC: 299.86 (unch), QLD: 151.26 (-1.50), VOO: 193.64 (-0.83), QQQ: 108.87 (-0.51), SDS: 20.69 (+0.17), BXUB: 201.74 (unch), PSQ: 56.14 (+0.28), UDOW: 150.49 (-2.01)

Reading The Tea Leaves Of Central Bank Policy
Investment Capitalist - at Seeking Alpha - Mon Mar 02, 3:17AM CST

SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), FXE: 109.94 (-0.06), IWM: 122.74 (-0.73), UUP: 25.24 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...